Latest News
-
HBS Reporting
Antibody protection after mild COVID-19 may not last; an estimated 100 mln people have had long COVID
Nov 18, 2021Nov 17 (Reuters) – The following is a summary of some recent studies on COVID-19. They...
-
HBS Reporting
Pfizer to allow generic versions of its COVID pill in 95 countries
Nov 17, 2021Nov 16 (Reuters) – Pfizer Inc (PFE.N) said on Tuesday it will allow generic manufacturers to...
-
HBS Reporting
Fauci says boosters for all key to U.S. reaching COVID-19 endemic level
Nov 17, 2021(Reuters) -Top U.S. infectious disease official Dr. Anthony Fauci said on Tuesday it is possible for...
-
HBS Reporting
Roche walks away from Atea partnership to develop COVID-19 pill
Nov 17, 2021Nov 16 (Reuters) – Roche Holding AG (ROG.S) has ended a partnership with Atea Pharmaceuticals Inc...
-
HBS Reporting
AstraZeneca-Oxford COVID-19 vaccine supply hits two billion doses
Nov 16, 2021Nov 16 (Reuters) – Two billion doses of the AstraZeneca-Oxford University COVID-19 vaccine have been supplied...
-
HBS Reporting
Explainer: Delta dominates the world, but scientists watch for worrisome offspring
Nov 16, 2021CHICAGO, Nov 15 (Reuters) – The Delta variant of the SARS-CoV-2 virus now accounts for nearly...
-
HBS Reporting
Amazon’s healthcare business has landed Hilton as a key customer
Nov 16, 2021Reuters) -Amazon. com Inc has reached a deal to sell virtual medical services to Hilton in...
-
HBS Reporting
Nigeria plans mass vaccination drive, considers booster shot
Nov 16, 2021ABUJA (Reuters) – Nigeria will start a mass COVID-19 vaccination campaign later this week, aiming to...
-
HBS Reporting
Beijing city tightens COVID guidance for travel from Chinese areas with overland ports
Nov 15, 2021BEIJING, Nov 14 (Reuters) – Beijing city said individuals who recently visited overland ports of entry...
-
HBS Reporting
Israel announces 5-11 year-olds now eligible for COVID-19 vaccination
Nov 15, 2021JERUSALEM (Reuters) – Israel said on Sunday that children aged 5 to 11 would now be...